Document z76dM27b2DmQj1Ej8dEma43R
AR226-3057
Study Title
100-Person Human Patch Test with H-22056 (Test Item)
Laboratory Project ID Haskell Laboratory Report No. 646-96
Study Completed On September 30. 1996
Contracting Laboratory
ConTox Limited 3408-50 B Street Philadelphia, Pennsylvania
19134
Author David Gabriel
for E. 1. du Font de Nemours and Company Haskell Laboratory for Toxicology and Industrial Medicine
Elkton Road. P. 0. Box 50
Newark, Delaware 19714
Study Monitor Gregory S. Ladies
Page I ol'iy
Company Sanitized. Does not contain TSCA CBI
Material Tested: Physical Form: Synonyms:
(iENERAUNFORMATlON-
Test Material
DuPont HLO 646-96
White Woven fabric
Stability:
Sponsor:
Study Initiated - Completed: In-Life Phase Initiated - Completed:
In the absence of visible evidence to the contrary, the test materials were assumed to be stable under the conditions of
administration.
DuPont Speciality Chemicals E. I. du Font de Nemours and Company Wilmington, Delaware
8/14/96-9/30/96
8/14/96-9/18/96
Company Sanitized. Does not contain TSCA CBi,
DuPoul HLO 646-96
DUPONTCENrRAIrRESEARCH-ANDDEVELOPMENTHASKELL LABORATORY FOR TOXICOLOGY AND INDUSTRIAL MEDICINE
ity Chemicals
October 8. 1996
100-Person Human Patch Test with H-22056 (Test Item)
Attached is a report from ConTox Limited (Project No. 96-8342H). report are patch test methods, results, and conclusions.
Included in the
The purpose of this study was to determine the potential of H-22056 to cause irritation or delayed contact hypersensitivity in humans. During the induction and challenge phases of this study, H-22056 (Test Item) produced no adverse skin responses in 100% and 100%. respectively,
of those subjects who were active participants.
Based upon the effects observed with the test materials placed repeatedly on the skin during both the induction and challenge phases, H-22056 (Test Item) is not considered to be a skin irritant nor a sensitizing agent under the conditions that prevailed in this study.
W u ^ Gregory S. Ladies, Ph.D.
Research Toxicologist
- 3
"Company Sanitized. Does not contain TSCA CBi
l)uPonlllLOfc646-96
ConTox Limited
I'.O. Ho\ ViK. I on Washington. Pennsylvania 19034-0368 Telephone: (215 739-4499 lax: (215)423-9210
Project Number:
96-K34211
Testing Facility:
ConTox Limited 135S l.yeoming Street Philadelphia. 1A 19124
Sponsor: Test Article:
R I. du Font de Nemours & C'ompany P.O. Hex 50. Hklon Road Newark. OF 19714
H-22056
Test Article Description:
White woven fabric
Test Article Received:
08/13/96
Study Initiated:
08/1496
Study Completed: 09/18/96
Date of Report: lest:
09/30/96 Modified Drai/c Repeated Insult Patch Test Study in Human Volunteers
Object of Test:
Reference:
Method of Test:
To determine the sensitizing properties of the test article.
The method employed in carrying out this lest was similar to that
described in "Appraisal of the Safety of Chemicals in Foods. Drugs and Cosmetics'' by .I.H. Draizc and published by the Association of Food and Drug Officials of the United States.
Test Panel: The lest involved the application of the test article to the upper arms of a group of 111 volunteer panelists. The panelists ranged from IX K 70 years of age (see Panelist List. Appendix II). One hundred and five panelists completed the study. Prior to the initiation of the study. all panelists were in good general health and tree of any visible skin
disease or anomaly in the area to he patched. Lach panelist was required to read. understand and sign an informed consent slalemenl.
Page 4 Company Sanitized. Does not contain TSCA CBI
Project Number: ^1^34211
l)uPonlllLO#64A-%
_1:. LiJiLPonLdL.Nemours & Compiiny I l-2205o
Modified Dr.ii/.c Repeated Insult Patch Test Study in llumun Volunteers
Mcihad-ojL-Lc^l; (continued)
P-aldi Prcpumlion: 'I'hc tcsl article was tested as supplied. 'I'he test article was cut into approximately tine inch square portions and placed onto a
strip of 2" Dormicel" hypoallergenic cloth tape (Johnson & Johnson, New Brunswick, NJ OKyo?). Before applying this strip, each portion of test
material was secured in place with a gloved finger to insure proper application. This tape strip was then pressed into place on the upper left arm ol'each panelist at its designated test site.
Induction Phase: I'he patch was applied to its designated contact site and remained in place lor 24 hours. At the end of this period, the patch was removed and the site was examined for any dermal response. The panelists were then rested I'or a 24-hour period after which the skin site was again examined. A new patch was then applied to the same site as previously used. Each subsequent application was identical to the first and remained in place 24 hours. This procedure was repeated on Mondays, Wednesdays and Fridays until a series of nine applications had been made. Patch applications made on Friday were removed by the panelists on Saturday.
The panelists examined the sites (with assistance if necessary) for any
dermal response at the time of removal and again at 48 hours and reported
their observations prior to the next application. The same site was used throughout the study.
In the event when one induction application was missed, the panelist was allowed to make it up at the end of the induction patch period. This patch was applied on Wednesday following the last scheduled (ninth) induction application on Monday.
Challenge Phase: After the th application, a rest period of approximately
2 weeks elapsed alter which a challenge application was applied in the same manner and to the same site as originally patched. A duplicate challenge application was also applied in the same manner to a virgin site (previously untreated) on the other arm. The challenge applications were removed after 24 hours and the sites were examined and graded for signs of irritation or sensiti/.alion. A follow-up examination was conducted at 48 hours after the challenge applications (24 hours after patch removal).
The grading scale used throughout both the induction and challenge phases is shown in Appendix 111.
( Ulllin I lilllk-.l -5- I'l' lli"> I'.X. lull \\.ls|]|lifl..n l'rl|]ls\l.1111.1 I'llHI-llK.X
Company Sanitized. Does not contain TSCA CBB
Project Number: %-K34211
Diil'onllll.()(4d-%
T Tl-du-l-'onl-de-Neinours-&_tA>'lin'!ij\ -1 l-2205f
Modified Drai/e Repealed Insult Patch lest Study in Human Volunteers
Refills; Conduiiion;
Results obtained with the lest article (11-2205(>) are presenled in Appendix
I. Individual panelist data are presented in I able I. data is presented in 'I able 2.
A summary of the
l-rom tile results obtained with this lest punel under the lest conditions utili/ed. the lest article does not appear to he a primary skin irritant. The test article does not appear to he a fatiguing agent. The test article does nut appear to he a sensiti/ing agent.
^SasslW&si
Submitted hv (.'on 1'ox Limited:
L j ^ J ^ ^ ^ ^ - ^ ^ yTredcrick I Irbach. M.D.
.' Consultant I )ermatologisl
i
__/^y<t<^.<^- /m^^f)
RaymonJ\1ark. M.D.
Study Director Consultant
^ f U Dale
Approved by:
-^^.C.^L-^^^^ KKaarrlll1.... CCiiaahhrriieel.l.VV..MM..ID)....II''hh.D.
President
1^ -/P/^/^L>
Date
t nnl.\ I iniilvil -n- ri> ll.\ li.X liiil \\.ishlll(!lini. 1'ciin^lvaiii.l |')(H.l.llli,x
Company Sanitized. Does not contain TSCA CBI
ComiMPV Ran't1'0^. OOP'S ""t ^""tain TRCA CB*
Project Number: 1 6-8342H h.l. tin Ponide Neincurs & Company - H-2205 6. assupp led. Modified Uraize R cpeulcd Insult Patch Test Sliidy in Hunnan Vtjiunteers
UuPout 1
Table 1 - Individual Panelist L)ws C
Iniduclio;jLEhase
Orig
Panelist
I
2
3
4
5
6
7
8
9
10* *
S
2422 2i45 Number 24 48
1
0
24 -4S 24 72 244,8 24 jm 2
24---48 24 48 24
0
0
0
0
0
0
0
0
0
00000 0000 2
0
0
0
0
0
0
0
0
0
0
00000 0000 3
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0000000000 00000000 00 00 5
0
0
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000 7 00000 00000000 8
0
0
0
00
00
0
0
0
0
0 0
)
0
0
0
0
0
0
0
0 0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000 000- 10
0
0
0
0
0
0
0
0
0
0
0
0000000000 0000000 11
0
0
0
0
0
0
0
-
0
0
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000 0000 13
0
0
0
0
0
0
0
0
0
0
0000 14
0
0
0
0
0
0
0
0
0
0
00000 0000 15
0
0
0
0
0
0
0
0
0
0
0
0000000000 0000000 16
0
0
0
0
1) 0
0
0
0
0
0
0
0
0
0
17
0000 18
0
0
0
00
00
0
0
0
0
0 0
0
0
0
0 0
0
0
0
0
0
0
0
0 0 0 0 19
0
0
0
0
0
0
0
0
0
0
00000 0000 20
0
0
0
0
0
0
0
0
0
0
00000 0000 21
0
0
0
0
0
0
0
0
0
0
00000 0000 22
0
0
0
0
0
0
0
0
0
0
00000 0000 23
0
0
0
0
0
0
0
0
0
0
00000 0000 24
0
0
0
0
0
0
0
0
0
0
00000 0000 25
0
0
0
0
0
0
0
0
0
0
0000000000 00000000 24 = Reading 24 hours after application.
. = Missed reading.
48 = Reading 48 hours after application.
72 = Reading 72 hours after application.
* = Panelist missed the scheduled patch application for personal reasons. Panelist was patched on the next scheduled application
day,and the patch series extended until 9 induction ap plications were applied.
** = Make-up patch application.
D = Discontinued from the study for personal reasons.
C w*Tos Lim nrf P 0
-8-
Box 168. tan Wihingun. P Biimylswr 19014JOKI
Project Number: 96-8342H E.I. du Font de Nemours & Company - H-22056, as supplied. Modified Draize Repeated Insult Patch Test Study in Human Volunteers
DuPont H
1rablf; 1 Individual panelist I:?ala a
IndiiictioiLChase
Orig
Panelisi1
1
2
3
4
5
6
7
8
9
1C>**
S
2422 Numbci[ 2448 26
2448 2448 24---4S ;24 72
0
0
0
24 M 24 -22 24---48 24---48 24
0
0
0
0
0
0
27
0
0
0
Q
0
0
0
0
0
000000 0000 28
0 0
0
0
0
0
0 0
0
00000000 0000 29
0
0
0
0
0
0
0
0
0
00 0000 0000 30
0
0
0
0
0
0
0
0
0
0000 0000
000000 0000 3
i 1
0
D
D
D D
D D
D D
D
D
D
D
D D
D D
D
D
32
0000 0000 33
00
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 0
0
34
.
0
0
0
0 0
0
0
0
000000 0000 35
0
0
0
0
0
0
0
0
0
000000 0000 36
0
0
0
0
0
0
0
0
0
000000 0000 37
0
0
0
0
0
0
0
0
0
000000 0000 38
0
0
0
-
0
0
0
0
0
0
0
0
0
0
00000000 0000 39
0
0
0
0
0
*
-
0
0
0
0 0
0 0
0
0
0
0000 40
0
0
0
0
0 0
0
0
0
0 0 0 0 41
0
0
0
0
0
-
0
0
0
0 0
0
0
0
0
0
000000 0000 42 0000 000- 43
00
0
0
0
0 0
0
0
0 0
0 0
0
0
0 0
0 0
0
0 0 0 0 44
0
D
D
D D
D D
D D
D D
D D
D D
D D
D
D
000000 0000 45
0
D D
D D
D D
D D
D D
D D
D D
D D
D
D
46
0
0
0
0
0 0
0 0
0
47
0 0
0
0
0 0
0 0
0
000000 0000 48
0 0
0
0
0
0
0 0
0
000000 0000 49
0
0
0
0
0
0
0
0
0
000000 0000 50
0 0
0
0
0
0
0 0
0
00 00 00 00 00 00 00000000 24 = Reading 24 hours after application.
= Missed reading.
48 = Reading 48 hours after applkation.
72 = Reading 72 hours after application.
*
s
** =
Panelist missed the scheduled patch applic-itkmfcrpe rsonal reasons. Panelist was patchedon the next scheduled aippiication
day. and the patch series extended un tii9iiiductiomapplications were applied.
Make-up patch application.
D = Discontinued from me study for personal reasons.
ronTox Limiud - P 0
-9-
Box 161. Fox WohinflMl. Pcniuylviu 190)4-016*
Project 1l'umber: 96-8342H E.l.duPoni dc Nemours & Company - H-220 56. as supp lied. Modidetd Draiz.e Repeated Insult Patch Test St udy in HurmanV olunteers
DuPont H
Tahle 1 - Individual Panelist t?aia Q
11id1uciuaiLEhasc
Orig
Panelist
I
2
3
4
5
6
7
8
9
10**
Sit
2422 -a Numhej 2448 51
2448 2448 2i
21 72
0
0
0
24 -42 24 Z2 24 4S 24----48 24
0
0
0
0
0
0
52
0
0
0
0
0
0
0
0
0
000000 0000 53
0
u
0
0
0
0
0
0
0
0
000000000000 0000000 54
0
0
0
0
0
0
0
0
0
55
0
0
0
0
0
0
0
-
0
000000 0000 56
0
0
0
0
0
0
0
0
0
000000 0000 57
0
0
0
0
0
0
0
0
0
000000 0000 58
0
0
0
0
0
0
0
0
0
000000 0000 59
0
0
0
0
0
0
0
0
0
000000 0000 60
0
0
0
0
0
0
0
0
0
000000 0000 61
0
0
0
0
0
0 0
0
0
0
000000000000 0000000 62
00.00 63
00
0 0
0 0
0 0
0
0
0
0
0
0
0
0
0
0
0
0
000000 00000000 g 64
0
0
0 0
0
*
-
0
0
0
0 0
0
0
0
00 3
65
0
0
0
0
0
*
.
0
0
0
0
0
0 0
0 0
0
0
0
0000 00 13
66
0
0
0
0
0
0
0
0
0
0000 0000 00 ^
67
0
0
0
0
0
0
0
0
0
S
68
0
0
0
0
0 0
0 0
0
000000000000 00000000 i.
69
000000 0000 8
70
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
P-
71
0
0
0
0
0
0
0
0
0
000000000000000000 00000000 00
72
0
0
0
0
0
0
0
0
0 0
0
(0 (/)
/iJi
0
0
0
0
G 0
0
0
0
0
D
DD DD DD
D
D
000000000000 00000000 00
74
0
0
0
0
0
0
0
0
0
<?
75
0
0
0
0
*
.
0
0
0
0
^3
S
24 = Reading 24 hours after application.
48 - Reading 48 hours after application.
- = Missed reading.
001 72 = Reading 72 hours after application.
>
* = Panelist missed the scheduled patch fapplication forpeTsonal reasons. Panelist wvas patched on the next scheduled application
0 03
day. and the patch series extended until 9 induetiona| iplications were applied.
5&
* = Make-up patch application.
D = Discontinued from the study for personal reasons.
-10-
c DnTox Liin ittd - P 0 Uai 161. Fon W-hinglon. Penl mylvui 1<M]-CD161
----^-------
v
Project Number: 96-8 j42H F.I. ilu Poni de Nemours & Company - H-22056. as supplied. Modified Draize Repeated Insult Patch Test Study in Human Volunteers
DuPont HL
TnMd-lnrtivirtualfaaeUsLfiaia Ch
induction Phase
Origi
" - ,, ,. , , , 4 5 6 7 8 9 10** Sit
=----^^^^^^2^2; ^ uOOOOOOOOOOOOOOOOO S ; 2 I ; S 2 ; 7; o
o
o
o o o o o o o
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00 0
0
000000000000000000 0 8,
0
C
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
82
8,
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8.
0
000000000000000000000000000000000000 0 86
87
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00.0000000000000000 88
0
0 0
0
0
0
0
0
89
0
0
0
0
0
0
0
0
0
0
0
90 91
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
oooooooooooooooooo n I0
9,
o
o
o o
o
o
o
o
o
o
o
o
o o
o o
o o
o
1 ^0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
-
OOO*-OOUDUDDDDDDDD D ^ 94 ,4
0
0
0
0
0
0
0
0
0
0
0
0
0 0
0
0
0
0
0
0
o
,(,000000000000000000 1: 0
,7000000000000000000 0
S 99
,8000000000000000000 o g OOOOOOOOOOOOOOOOOO 100
o
o
o o
o
o
o o
o o
o
o
o o
o o
o o
3
2-
24 = Reading 24 hours after application.
S
48 -E Reading 48 hours after application.
...,.,
72 = Reading 72 hours after application.
5-
* = panelist missed the scheduled patch application for personal reasons. Panelist was patchedon the next scheduled apprlica.t.ion
(3
day. and the patch scries extended until 9 induction applications were applied.
2
** = Make-up patch application.
0
n"
Ra
fonTo Limittd P " B>. )M. l-'on Winhmimiii PcnwylvBlit 1W1+016S
-------------
Project Number: tb-K.^II
F..1. du Pom de Nemours & Company - H-22056. as supplied. MoJifieJ Drai^e Repealed Insult Patch Test Stud> in Human Volunteers
DuPoni
Table 1 - Individual Panelist Data
C
Induction Phase
Ori
1 2 3 4 5 6 7 8 9 Panelist
10**
S
Number
101 102
000000000000000000 HAS .a22 2448 2448 2472 2445 2448 2422 2442
OOOOOOOOODDDDDDDDD
244B
24
0D
103 104 105 106
00000000000000000000000000000000000000000000000000000000000000000000000-
00 00
107 108 104 110
00000000000000000000000000000000000000000000000*00-0000 000-000000000000
00 00
00 00
111 000000000000000000 0
0
0
3 0
D)
^
01
01 3
S
Q"
o
S
!^
1
(U
5"
-COI
0 te,
,
i
24 = Reading 24 hours after application.
- = Missed reading.
48 = Reading 48 hours after application.
72 = Reading 72 hours after application.
* =- Panelist missed the scheduled patch application for personal reasons. Panelist was patched on the next sched uled application
day. and the patch series extended until 9 induction applications were applied.
** = Make-up patch application.
D = Discontinued from the study for persona! reasons.
'
.
-I2I -
ConTox Limittd P 0 Box Ml, Foil Wuhinpon. tamylvuil 140144161
I'rojecl Number: *M)-834;H F 1. du Font de Nemours & Compan\ - H-22056. as supplied. Modified Drai/e Repealed Insult Patch Test Study in Human Volunteers
DuPoni H
Table 2 . Summary of Data Cb
y;1a 23456789 Ida)
Eanelias; 111 111
2472
III 111
2448
111 III
Induction Phase
2448
III 111
2422
111 111
2448
111 III
2442 2422
III 111 III 111
244S
111 111
10*
2442
9 9
Orig Sit
244
III
Grade
0
111 108 108 107 107 102 101 107 107 106 105 104 102 103 103 105 104 103
9 9
105
;
1-
00 00 00 00 00 0000 CO 00 00
000000000000000000 00
00
23-
000000000000000000000000000000000000
00 00
00
4- 00 00 00 00 00 00 00 0000 00 0
9
0)
<3
000000011006700000000001300220000102
0 0
11 D 033333344566666666 6
S
24 -- Reading 24 hours after application.
= Missed reading.
0
48 = Reading 48 hours after application.
t?
72 = Reading 72 hours after application.
0
3.
* = Panelist missed the scheduled patch application for personal reasons. Panelist was patched on the next sche< luted application
B).
day, and (he patch series extended until 9 induction applicationswere applied.
3
** - Make-up patch application.
D = Discontinued from the study for personal reasons.
W
^
0
S
-13-
ConTo Lmilled . P 0 Box Ibl. Fon Wishmgttn. Pttimylvtrin 19014068
Project Number: 96-8342H
DuPont HLO # 646-96
E.I. du Font de Nemours & Company - H-22056______________________
Modified Draize Repeated Insult Patch Test Study in Human Volunteers
APPENDIX II PANELIST LIST
-14-
(onTox Limited PO llox fhH. hid Waihinglon. Pennsylvania 1<H)}4-036R
Company Sanitized. Does not contain TSCA CBS
Project Number: 96-8342 H
DuPontHLO# 646-96
E.I. du Font de Nemours & Company - H-22056
Modified Draize Repeated Insult Patch Test Study in Human Volunteers
Panelist Number
1
'
^
.
4' 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
20
21 22 23 24 2526 27 28 29
30
31 32 33
34 35 36 37 38 39 40
Panelist Initials
M.C. M.T. C.P. B.R. E.T. B.H. N.R. R.O.
J.B. A.B. L.P. M.C. H.D. B.B. A.D.
C.M. R.D. C.M. D.P. A.B. M.D. M.M.E. M.A.E. L.D. D.P. L.M.
J.C. E.P.
A.G. J.W. M.H. N.D. M.C. L.C.
S.S. P.W.
E.W. L.B. K.M. E.M
PANELIST LIST
Age
Occupation
23
Supervisor
33
Meat packer
31
Medical assistant
30
Homemaker
41
DentuI assistant
37
Homemaker
36
Homemaker
41
Homemaker
44
Newspaper clerk
32
Homemaker
36
Homemaker
30
Homemaker
53
Homemaker
29
Homemaker
30
Salesperson
36
Salesperson
49
Homemaker
26
Homemaker
37
Cashier
31
Laborer
34
Homemaker
36
Homemaker
55
Homemaker
27
Medical Assistant
35
Homemaker
39
Homemaker
20
Student
38
Boxspring maker
52
Homemaker
47
Uemployed
44
Unemployed
34
Student
46
Homemaker
18
Student
37
Homemuiier
38
Homemalier
42
Homemaker
57
Homemaker
34
Homemaker
53
Homemaker
Allergies
Ragweed Penicillin Shellfish, seafood Hayfever
Penicillin, ampicillin, amoxicillin
Penicillin, aspirin Hayfever
-15(onTo< I imilcil - I'f Hi< Ihll. hut WiKhinplnn. 1'cnn.sylvania IWM-OIMI
Company Sanifeed. Does not contain TSCA CBft
Project Number: 96-834211
DuPont HLO # 646-96
E.I. du Pont de Nemours & Company - H-22056
Modified Draize Repeated Insult Patch Test Study in Human Volunteers
Panelist Number
41 42 43 44 45 46 47
48 49 50
51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68
69 70
71 72 73 74 75 76 77 78 79 80
Panelist Imtiajs
M.G. S.V. J.H. B.A. H.O. D.G. D.R. P.D. A.T. K.H. V.T. P.A. M.W. T.T. J.N. J.D. J.D. O.K. M.S. J.Z. Y.H. C.R. S.B. H.R. C.R. P.O. C.R. W.C. T.F. R.D. K.A. E.L. M.L. T.E. M.C D.Y. A.G. A.G.
J.F.
D.D.
Age
39
31
26 49 20 33 49 35 57 26 37 35 67 31
31 31 33 36
60 62 40
18
29 38 18 26 28 24
21 26 26 47 39 24 50 59 65 64 42 58
Occupation
Day care teacher Homemaker Typist Homemaker Student Homemaker Homemaker Teaching assistant Bakery worker Homemaker Homemaker Unemployed Homemaker Homemaker Printer Homemaker Homemaker Homemaker Retired Homemaker Homemaker Student Daycare worker Unemployed Student Homemaker Homemaker Student Supermarket worker Unemployed Homemaker Day care teacher Homemaker Homemaker Day care teacher Upholsterer Salesperson
Homemaker Unemployed Crossing guard
-
1Penicillin
/Animals, dust, pollen IHayfever FPenicillin, aspirin, tetanus toxoid tHayfever
Animal hair, hayfever Penicillin
Penicillin, aspirin. Darvocet, codeine DDust, grass, trees, pollen, smoke Pienicillin
- (6.
1'iinTtK I imilci) -I'll HIIK M'K. l-'nn Washington. I'cnnsvlvaniu l'"H4-(l>H
C. TOy Sanitized. Doss no, confab TSCA ^
Project Number: 96-8342H
DuPontHLO# 646-96
-K;l^duPontdeNemours&Company^H-22Q56_
Modified Draize Repeated Insult Patch Test Study in Human Volunteers
Panelist
Number
81 82 83 84
85 86 87 88 89 90 9) 92 93 94 95 96 97 98 99 100
101 102 103 104 105 106 107 108 109 110
III
Panelist
Initials
H.R. K.B. D.R. A.B. W.M. S.M. J.M. B.M. C.J. A.N. C.C. V.M. N.S. V.S.
J.S. R.S. E.N.
D.H. J.H. D.I K.N. B.M V.F. L.T. E.G. M.C. R.F. M.S. R.P. E.D. J.B.
Age
18 32 31 70 30 26 45 43 39 48 19 31 37 24 35 52 52 40 49 39 33 48 48 27 43 27 47 38
18 33 28
PANELJST.UST
Occupation
Student Homemaker Homemaker Homemaker Waitress Hairdresser Printer Secretary Homemaker Processor Student Student
Unemployed Unemployed Homemaker Unemployed Physical therapist
Secretary Machine operaor Office worker Accounts payable Homemaker Welder Homemaker Homemaker Laborer Congressionalaide Payroll clerk Unemployed Hairdresser Isurance adjuster
AJler&ies
Sulfur
Hayfever Hayfever Penicillin Animal hair
Metals Antibiotics Cats Hayfever
-17- ( on I ^ I mined - P l' Hi" r'H. I"" WiKhinslnn. Pennsylvania |W<4-".W>X
Company Sanitized. Does not contain TSCA CB
hoicct Number: %-K34211
DuPont 111.0 # 646-Wi
-l;7l-Jii-l*<>nide-Ncm(Uirs<fe-C-'onipany-^ll-22(5A_________________________
Mudil'ied Dmi/.e Repealed Insult I'alch lest Study in Human Volunteers
APPENDIX III GRADING SCALEi
- IS-
1 riil,", I iiiiiicil-l'u H.'i ll'l' Irn W;isliiiirl.iiil'ciiirJ;iiii.i I'llll.l-nll.K
Company Sanitized. Does not contain TSCAC8|
Project Number: 96-(n421 1
DuPont HLO # 646-96
I-:.!, du Font de Ncmours & Company - 11-22056_________________________
Modillcd Drai/.c Repeated Insull Patch Test Study in Human Volunteers
Appendix HI Human Patch lest Studies Grading Scale
Reading
0
+
1+ 2+ 3+
4+
Inlerpretation negative suspicious slight erythema well defined erythema erythema with induration erythema with ulceration
DEFINITIONS*
Sensitization is a phenomenon which manifests itself by local effects on either skin or mucous membranes. It differs from primary irritation in that it may also involve tissues remote
from the site of application. These reactions represent w allergy to a chemical which is not obtained on first contact, but requires a number of prior exposures for development.
Repeated patch applications of substances to both man and animals reveal that certain
substances which, at a given concentration, do not produce primary irritation may elicit severe
skin reactions after a number of exposures. Nevertheless, these reactions may not be considered incidents ofsensitization since after 10-14 days of rest the skin recovers its original resistance to injury by the substance. For the lack of a better term such reactions have been called "skin
fatigue". This latter term is a misnomer in that it does not imply a condition in which the skin has
lost significant normal physiological function. This phenomenon consists of a subtle change in
which the skin no longer exhibits its original refractoriness or resistance to the continued or
repeated action of an agent.
* Drai/c. J.I I. 1959. Appraisal of the Safety of Chemicals in Foods. Drugs and Cosmetics. In DI:RMAI. TOX1CII Y. p. 46-53. Topuka. Kansas: Association of Food and Drug Officials of
(he United Slates.
- 19( iilii\ I iiinlL-il -I'd lli>\ KiK. Inrl Wilsliuit!liiii. rmn-.i.k.ini.l I'MIU.II.'fiK
Company Saoitizeff. Does not<;ontain TSCAC